1. Development of ex vivo phenotypic assays to enable precision medicine in the context of high grade serous ovarian cancer. (July 2016) Authors: Nelson, L.; Tighe, A.; Clamp, A.; Edmondson, R.; Jayson, G.; Taylor, S. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK. Issue 12 (December 2016) Authors: Khoja, L.; Nolan, K.; Mekki, R.; Milani, A.; Mescallado, N.; Ashcroft, L.; Hasan, J.; Edmondson, R.; Winter-Roach, B.; Kitchener, H.C.; Mould, T.; Hutson, R.; Hall, G.; Clamp, A.R.; Perren, T.; Ledermann, J.; Jayson, G.C. Journal: Clinical oncology Issue: Volume 28:Issue 12(2016) Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗